- Efficacy and Mechanism Evaluation (EME)
- Health Service & Delivery Research (HS&DR)
- Health Technology Assessment (HTA)
- Invention for innovation (i4i)
- Programme Development Grants (PDG)
- Programme Grants for Applied Research (PGfAR)
- Public Health Research (PHR)
- Research for Patient Benefit (RfPB)
EME bridges the gap between preclinical studies and evidence of clinical efficacy. The aim is to secure the progress of new technologies and interventions through their early clinical trials and onto larger, later clinical trials. The programme supports science driven studies with an expectation of substantial health gain, and aim to support excellent clinical science. The clinical research that is funded is underpinned by robust scientific evidence and is focused on the potential to benefit patients in the medium to longer term.For more details visit the EME Remit page.
HS&DR funds research to produce rigorous and relevant evidence on the quality, accessibility and organisation of health services, including costs and outcomes. This includes evaluations of how the NHS might improve delivery of services. The audience for this research includes the public, service users, clinicians and managers. The programme enhances the strategic focus on research that matters to the NHS including research on implementation and a range of knowledge mobilisation initiatives. HS&DR supports a range of types of research including evidence synthesis and primary research. This includes large scale studies of national importance. For more details visit the HSDR Remit page.
HTA funds research about the effectiveness, costs and broader impact of healthcare treatments and tests for those who plan, provide and receive care in the NHS. The term 'health technology' covers a range of methods used to promote health, prevent and treat disease and improve rehabilitation and long term care including drugs, devices, procedures, settings of care and screening. For more details visit the HTA Remit page.
i4i aims to advance the research and development of innovative healthcare technologies and their translation into the clinical environment for the benefit of patients by:
- Guiding the progression of innovative medical product prototypes, and
- Providing business advice to the medical technology professionals it funds.
The programme supports projects from prototype and commercial development to introduction and adoption in the NHS.
i4i will support projects developing any innovative medical technology including medical devices, active implantable devices and in vitro diagnostic devices. i4i will also support projects that utilise and develop techniques or technologies from other industry sectors that could have a potential impact if applied in a healthcare setting.
Project teams from Wales, or those involving collaborators based in Wales, are welcome to apply for funding through the i4i Product Development Awards.
The i4i Challenge Awards address particular ‘challenges’ that are a priority for the NHS and aim to bridge the gap between the innovation and development of new medical technologies and their adoption into clinical pathways.
The 3rd i4i Challenge Awards call is now closed.
The i4i Life Sciences Accelerator programme is designed specifically to help health and medtech researchers maximise their chances of success when applying for funding and investment.
The programme has been developed by i4i, along with experienced medtech industry experts, to equip researchers in industry, academia and the NHS with the skills and knowledge required to put together robust business plans and strong funding applications that will satisfy funding panels, investors and external experts. For more details visit the i4i web page.
Programme Development Grants are a complementary scheme to allow investigators to undertake preparatory research that will position them to submit a competitive Programme Grant application. Programme Development Grants are designed to increase the rate and number of successful applications for a full Programme Grant. For more details visit the PDG web page.
Individual awards are for a maximum of £100k over a period of six to eighteen months. The amount of funding awarded, however, is determined by the scale and nature of the research activity to be conducted.
Programme Grants aim to produce independent research findings that will have practical application for the benefit of patients and the NHS in the relatively near future. For more details visit the PGfAR web page.
The PHR Programme funds research that evaluates public health interventions, providing new knowledge on the benefits, costs, acceptability and wider impacts of non-NHS interventions intended to improve the health of the public and reduce inequalitites in health. The scope of the PHR Programme is multidisciplinary and broad, covering a range of public health interventions. For more details visit the PHR Remit page.
RfPB is a national, response-mode programme inspired by patients and practice to generate high quality research for the benefit of users of the NHS in England. Its main purpose is to realise, through evidence, the huge potential for improving, expanding and strengthening the way that healthcare is delivered for patients, the public and the NHS. For more details visit the RfPB Remit page.